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Spurious thrombocytopenia, also called Pseudo- 
thrombocytopenia (PTCP), results from low platelet counts due to in vitro 
platelet clumping [1-7]. Platelet clumping in PTCP results in inaccurate 
platelet concentration, which leads to misdiagnosis of thrombocytopenia 
when analyzed with hematology analyser [7-8]. 
                   Frequency of 0.3% and 1.2% respectively was reported by 
Mant et al[9] and Manthorpe et al[10], which referred however to a small 
case series. This type of alteration is now familiar to the clinical 
pathologist; and consequently it has been evaluated more accurately, and 
at present its frequency is considered to be within range of 0.09 – 0.11% 
[11]. Although PTCP is an infrequent condition, it accounts for a sizable 
fraction of all the cases of “thrombocytopenia” that are referred to for 
further evaluation [12]. 
Pseudothrombocytopenia (PTCP) is an immunologically 
mediated phenomenon caused by the presence of EDTA – dependent cold 
anti-platelet auto-antibodies in blood that cause in vitro platelet clumping 
as shown in figure 1 – A, B [5,7,13-15]. 
           In automated electronic cell counting of blood samples 
anticoagulated with edetic acid, PTCP was observed due to in vitro 
platelet clumping induced by edetic acid. It is caused by activation of an 
abnormal protein identified as an immunoglobulin/ agglutinin [5, 7, and 
16]. The mechanism of EDTA induced platelet clumping may be related to 
the physiological function of the platelet membrane, as EDTA modifies 
platelet and red blood cell membranes, in presence of reduced calcium 
concentration [17]. The phenomenon appears to involve a protein 
fraction with some relation to fibrinogen, which in some cases, is an IgM 
or IgG antibody against platelet antigens that is maximally reactive at low 
calcium concentrations [12, 16, 17]. 
                 Pseudothrombocytopenia may lead to the erroneous diagnosis 
of thrombocytopenia, with resultant unnecessary and costly additional 
laboratory testing, inappropriate treatment with delay of surgery and 
unwarranted exposure to transfusion-related complications; all being the 
potential outcomes for an individual with this form of in vitro artefact 
[15,18,19]. 
 
Fig.1 (A, B): Platelet clumps in EDTA-anticoagulated blood. 
                                                            
 
Abstract 
Objectives: To evaluate and compare the cases of EDTA-PTCP with actual platelet counts at 
different time intervals with new anticoagulant. 
Methods: This cross–sectional study was carried out in rural tertiary centre in central India. Blood 
samples were collected in K3-EDTA and CPT vials separately and subjected for peripheral smear 
examination and manual platelet counts. Comparison of platelet counts obtained by automated cell 
counter at 30 minutes, 3-4 hours and at 24 hours of blood collection from both anticoagulants and 
with manual counts was done. 
Results: The platelet counts in EDTA anticoagulated blood on suspicion of thrombocytopenia, as 
well as even after collection of fresh blood sample from same patient in EDTA and the counts at 
different time intervals showed significantly lower counts than that observed in CPT 
anticoagulated blood at the parallel time intervals and than that in the manual platelet counts. 
Conclusions: Unrecognized PTCP may result in unnecessary laboratory testing, bone marrow 
aspiration and unwarranted transfusions and will prevent needless evaluations of 
thrombocytopenia and related therapeutic decisions. 
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2. Methods 
This Cross sectional study was carried out in the Hematology 
division of the Department of Pathology, over a period of 2 years from 
May 2011 to May 2013, in a medical institute in central India.  
Subjects: 
Inclusion criteria: 
All the cases in which the automated counter report showed 
thrombocytopenia with platelet counts less than 130 x 109/litre with 
peripheral blood film examination showing platelets in fair number, 
either diffusely distributed or in clumps or aggregates and appeared to 
be within normal limits; were considered as Pseudothrombocytopenia 
and  included in the study. 
Exclusion criteria:  
1) The platelet counts between 130-150 x 109 /litre were 
excluded. 
2) The cases with known cause for thrombocytopenia as obtained 
from history, clinical examination and medical records, were 
excluded. 
Study methodology:  
 Blood samples were collected in K3-EDTA and CPT (trisodium 
citrate, pyridoxal 5'-phosphate and Tris) vials separately and 
examination of well prepared, air-dried, labeled peripheral smear stained 
with Leishman was done. Examination was done using light microscope 
under oil immersion (100x) with (10x objectives) for evaluation of 
platelet morphology, clumps, and counts. For EDTA-PTCP cases, the 
manual platelet count is considered ‘gold standard’ for this comparison 
as reported by Hyun-Sook Chi[15] and Lippi et al[17]. This method was 
performed using improved Neubauer’s chamber. Convenient procedure is 
to count five groups of 16 small squares in the central area (0.02µl). 
 
   Platelet count per litre    = Number of cells counted x Dilution x 106 
                                                       Volume counted (µl) 
To ensure a coefficient of variation of 8-10 %, the total number 
of platelet count should always exceed 200. 
 Using automated blood analyser, platelet counts 
were obtained at 30 minutes, 3-4 hours and at 24 hours of blood 
collection. 
 Thus, the platelet counts obtained by manual method; by 
automated counter at 30 minutes, 3-4 hours and at 24 hours of blood 
collection using two different anticoagulants were compared and these 
were also compared with the initial platelet counts on which 
pseudothrombocytopenia was suspected.. 
 The data is recorded and findings were analyzed statistically 
using z-test and test statistics. The software used in the analysis is SPSS 
17.0 version and graph pad prism 5.0. The p-value of less than 0.05 is 
considered as statistically significant. 
 
3. Results 
  In the present study, we assessed the cases of suspected EDTA 
- dependent Pseudothrombocytopenia (showing thrombocytopenia on 
initial automated platelet counts from EDTA anticoagulated blood with 
adequate platelet count and presence of platelet clumps in the peripheral 
blood smear) for accurate platelet count with manual method and also 
using EDTA and CPT as anticoagulants with automated platelet counts at 
different time intervals. 
    Study included 43 males and 60 females with M: F ratio of 
1:1.3. The patient’s age varied from 3-85 years with the mean age of 
36.78 ± 20.33 years. No significant association was found with respect 
age or distribution of cases. EDTA-PTCP cases were found to be 
associated both in health and disease state.  
The present study compared the mean platelet counts in EDTA 
anticoagulated blood on initial suspicion of pseudothrombocytopenia 
and at different time intervals after collection of fresh blood sample from 
same patients in EDTA anticoagulant with parallel platelet counts in CPT 
anticoagulated blood and also with manual platelet counts. 
The study observed the mean initial platelet counts in EDTA 
(103.67 ± 25.34 x 109/l) to be much lower than the mean manual platelet 
count (222.63 ± 85.22 x 109/l) and the difference was statistically 
significant. The mean platelet count in EDTA anticoagulated blood at 0-30 
minutes and at 3-4 hours (171.40 ± 78.10 x 109/l) and (171.63 ± 81.16), 
though it was in the normal range, was also significantly lower than mean 
manual platelet count and the parallel automated platelet count in CPT 
anticoagulated blood (226.63 ± 93.25 x 109/l) and (230.25 ± 97.57) at 0-
30 minutes and 3-4 hours respectively (Table 1). 
 
Table 1: Showing comparison of initial platelet count suspicious of pseudothrombocytopenia with manual platelet count and platelet count 
in EDTA and CPT anticoagulated blood at 0-30 minutes and at 3-4 hours. 
Number of cases Mean initial platelet count 
(x 109/l) 
Mean manual platelet count 
(x 109/l) 
Mean automated platelet count  
(x 109/l) at 0-30 minutes 
Mean automated platelet count  
(x 109/l) at 3-4 hours 
EDTA CPT EDTA CPT 
103 103.67 ± 25.34 222.63 ± 85.22 171.40 ± 78.10 226.63 ± 93.25 171.63 ± 81.16 230.25 ± 97.57 
Initial Platelet Count p-value 0.000, S, p<0.05 0.000, S, p<0.05 0.000, S, p<0.05 0.000, S, p<0.05 
Manual Platelet Count p-value 0.000, S, p<0.05  0.74,  NS, p>0.05 0.000, S, p<0.05 0.55 NS, p>0.05 
Initial Vs Manual Platelet Count p-value 0.000,S,p<0.05 0.000,S,p<0.05 
S: Significant; NS: Not significant 
    
 The present study also assessed the changes in the platelet 
counts in anticoagulated blood samples after preserving the blood 
samples at 3-4°C in a refrigerator for 24 hours, in total 74 cases. The 
mean platelet counts in EDTA and CPT anticoagulated blood were found 
to be 183.70 ± 100.21 x 109/l and 266.04 ± 103.51 x 109/l respectively. In 
the same cases, the mean initial platelet count was 100.51 ± 26.57 x 109/l 
and the manual platelet count was 240.68 ± 89.24 x 109/l, as shown in 
table 2. 
 
Table 2: Showing comparison of initial platelet count suspicious of pseudothrombocytopenia with manual platelet count and platelet count 
in EDTA and CPT anticoagulated blood at 24 hours. 
Number of cases Mean initial platelet count 
(x 109/l) 
Mean manual platelet count 
(x 109/l) 
Mean automated platelet count (x 109/l) 
EDTA CPT 
74 100.51 ± 26.57 240.68 ± 89.24 183.70 ± 100.21 266.04 ± 103.51 
Initial Platelet Count 
z-value 6.90 13.32 
p-value 0.000, S, p<0.05 0.000, S, p<0.05 
Manual Platelet Count 
z-value 3.65 1.59 
p-value 0.000, S, p<0.05 0.11 NS, p>0.05 
Initial Vs Manual Platelet Count 
z-value 12.95 
p-value 0.000, S, p<0.05 
S: Significant; NS: Not significant 
 
                  By using z-test, statistically significant difference was found 
between initial platelet count and platelet count in EDTA anticoagulated 
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blood at 24 hours (z = 6.90; p = 0.000), and between initial platelet count 
and platelet count in CPT anticoagulated blood at 24 hours (z = 13.32; 
p=0.000). 
          Similarly, statistically significant difference was found between 
manual platelet count and platelet count in EDTA anticoagulated blood at 
24 hours (z= 3.65; p = 0.000); but no significant difference was found 
between manual platelet count and  platelet count in CPT anticoagulated 
blood at 24 hours (z = 1.59; p=0.11) also.  
          Thus, the platelet counts in EDTA anticoagulated blood on 
suspicion of thrombocytopenia, as well as even after collection of fresh 
blood sample from same patient in EDTA and the counts at 0-30 minutes, 
3-4 hours and after 24 hours showed significantly lower counts than that 
observed in CPT anticoagulated blood at the parallel time intervals and 
than that in the manual platelet counts. Thus, we found the difference of 
initial mean platelet count in EDTA with manual platelet count of 55% 
and the difference of mean platelet count in EDTA and CPT 
anticoagulated blood of about 25% with counts at 0-30 minutes and at 3-
4 hours, and of about 31% at 24 hours. Thus, low platelet counts were 
probably because of the effect of EDTA anticoagulant on platelets. 
         The mean automated platelet counts in CPT anticoagulated 
blood at 0-30 minutes and at 3-4 hours as well as at 24 hours after blood 
collection were found to be comparable with the mean manual platelet 
counts. Thus, the CPT anticoagulant was found to be a better 
anticoagulant for getting correct platelet counts in cases of EDTA- 
dependent pseudothrombocytopenia. 
The present study also compared the initial platelet count in 
EDTA (103.67 ± 25.34 x 109/l) with that at 0-30 minutes (171.40 ± 78.10 
x 109/l) and at 3-4 hours (171.63 ± 81.16 x 109/l) in the same 
anticoagulant. The statistical analysis is shown in table 3: 
 
Table 3: Showing comparison of initial platelet count in EDTA anticoagulated blood with that at 0-30 minutes and 3-4 hours in same anticoagulant. 
Descriptive Statistics: 
EDTA No. of cases Mean platelet count x 109/l Standard Deviation Standard Error Mean 
Initial 103 103.67 25.34 2.49 
0-30 min 103 171.40 78.10 7.69 
3-4 hrs 103 171.63 81.16 7.99 
 
Wilcoxon Signed Rank Test: 
Paired Differences 
z df p-value 
 Mean Std. Deviation Std. Error Mean 
95% Confidence Interval of the Difference 
Lower Upper 
Initial &  0-30 min 67.72 80.45 7.92 52.00 83.45 8.54 102 0.000, S, p<0.05 
Initial &3-4 hrs 67.95 82.375 8.11 51.85 84.05 8.37 102 0.000, S, p<0.05 
0-30 min & 3-4 hrs 0.22 28.45 2.80 5.33 5.783 0.08 102 0.937,  NS, p>0.05 
        
                     By using Wilcoxan signed rank test, significant difference was 
found between initial platelet count and that at 0-30 minutes (z = 8.54; p 
= 0.000); and between initial platelet count and that at 3-4 hours (z = 
8.37; p = 0.000); but, no statistical change was found in platelet count 
from 0-30 minutes to 3-4 hours (z = 0.08; p = 0.937). 
Similarly, the initial platelet count in EDTA was compared with the 
platelet count in CPT anticoagulated blood at 0-30 minutes and at 3-4 
hours. The statistical analysis is shown in table 4: 
 
Table 4: Showing comparison of initial platelet count in EDTA with platelet counts in CPT anticoagulated blood at 0-30 minutes and at 3 - 4 hours. 
Descriptive Statistics: 
CPT No. of cases Mean platelet count x 109/l Std. Deviation Std. Error Mean 
Initial 103 103.67 25.34 2.49 
0-30 min 103 226.63 93.25 9.18 
3-4 hrs 103 230.25 97.57 9.61 
 
Wilcoxon Signed Rank Test: 
Paired Differences 
z df p-value 
 Mean Std. Deviation Std. Error Mean 
95% Confidence Interval of the Difference 
Lower Upper 
Initial & 0-30 min 122.95 96.16 9.47 104.15 141.74 12.97 102 0.000, S, p<0.05 
Initial & 3-4 hrs 126.57 100.48 9.90 106.93 146.21 12.78 102 0.000, S, p<0.05 
0-30 min & 3-4 hrs 3.62 18.82 1.85 0.05 7.299 1.95 102 0.054, N.S, p>0.05 
 
  By using Wilcoxan signed rank test, statistically significant 
difference was found between initial platelet count in EDTA 
anticoagulated blood with platelet count in CPT anticoagulated blood at 
0-30 minutes (z = 12.97; p = 0.000) and that at 3-4 hours   (z = 12.78; p = 
0.000); but no statistical change was found in platelet count from 0-30 
minutes to 3-4 hours (z = 1.95; p = 0.054) in CPT anticoagulated blood. 
 
4. Discussion 
            The present study entitled, “Ethylenediaminetetraacetic acid 
(EDTA) - Dependent Pseudothrombocytopenia”, was carried out in the 
Department of Pathology in a medical institution in central India. Total of 
103 cases of suspected EDTA-dependent Pseudothrombocytopenia 
(EDTA-PTCP) were assessed for its correctness using manual platelet 
count as the gold standard. The platelet counts in two different 
anticoagulants (EDTA and CPT) were compared at different times from 
the time of collection of blood sample. 
Prevention of platelet aggregation in EDTA-PTCP cases using 
CPT anticoagulant (Citric acid tri-sodium salt dehydrate, Pyridoxal 5’-
phosphate, Tris/ hydroxymethyl/ aminomethane) is opined by Lippi et al 
[17]; Lam et al [20]; Paparo et al [21] and Lippi and Faschinetti [22]. Most 
of the studies have tried different other anticoagulants to get correct 
platelet count in cases of EDTA-PTCP and have found CPT anticoagulant 
as a better alternative for EDTA in cases of EDTA-PTCP [15,17,20] similar 
to the present findings. The present study used manual platelet count to 
be the gold standard for platelet count in EDTA-PTCP cases [15, 17]. 
         The study included 103 cases, of which 9 cases were found to 
be incorrect. Incidence of thrombocytopenia in 1.5% cases was noted and 
that of EDTA-dependent Pseudothrombocytopenia in 0.07% cases of 
total haemograms and 4.9% of total thrombocytopenia was observed. 
The study was comparable with incidence of 0.03-1.9% as reported by 
Sakurai et al[23]. 
 The study compared the mean platelet count obtained in EDTA 
and from CPT anticoagulated blood at different time intervals with that of 
manual platelet count and with initial platelet count on which suspicion 
of PTCP was based. 
           The mean initial platelet counts in EDTA (103.67 ± 25.34 x 
109/l) were much lower than the mean manual platelet count (222.63 ± 
85.22 x 109/l) and the difference was statistically significant. The mean 
platelet count in EDTA anticoagulated blood at 0-30 minutes and at 3-4 
hours (171.40 ± 78.10 x 109/l) and (171.63 ± 81.16 x 109/l) respectively, 
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though it was in the normal range, was also significantly lower than mean 
manual platelet count  and the parallel automated platelet count in CPT 
anticoagulated blood (226.63 ± 93.25 x 109/l) and (230.25 ± 97.57 x 
109/l) at 0-30 minutes and at 3-4 hours respectively (Table 1). 
                  In 74 cases, the platelet counts were compared after 24 hours of 
preservation of blood sample. Even at this time, the mean platelet count 
in EDTA anticoagulated blood was significantly lower than that in CPT 
anticoagulated blood (Table 2).The present study observed the difference 
of mean initial platelet count in EDTA with manual platelet count of 55% 
and the difference of mean platelet count in EDTA and CPT 
anticoagulated blood of about 25% at 0-30 minutes and at 3-4 hours, and 
of 31% at 24 hours. 
          None of the studies reviewed have shown the comparison of the 
mean platelet counts in EDTA with manual platelet counts and with that in 
other anticoagulants, except for the study of Lippi et al[17] where they 
compared the automated platelet counts in EDTA and CPT anticoagulated 
blood in 4 different make cell counters with the mean manual platelet counts. 
The mean automated platelet counts in STKS coulter counter in EDTA and 
CPT anticoagulated blood were found to be 101.75 ± 49.22 x 109/l and 256.25 
± 80.08 x 109/l respectively, whereas, the mean manual platelet count was 
255.31 ± 82.82 x 109/l. These findings well correlate with that of the present 
study.  
               Different workers explained this phenomenon in different 
ways. The basic fact is there is in vitro binding of antibodies in the blood 
with some antigenic determinant on the platelet membrane in presence 
of EDTA which results in formation of platelet aggregates. The size of 
these platelet aggregates are beyond the upper limit of discrimination of 
platelet width of the automated cell counters and hence they are counted 
in the WBC channel and omitted from the platelet channel resulting in 
low platelet counts shown by automated blood cell counters.  
         The target antigen on platelet is a cryptic epitope that is 
normally hidden in platelet membrane glycoprotein; the glycoprotein 
being GP IIb/IIIa[24]. Although EDTA-PTCP have been reported in 
variety of diseases (autoimmune, neoplastic, liver, cardiovascular, viral 
etc.), a documented trigger for the production of antiplatelet antibodies is 
unknown[25]. Lelie et al[26] showed that the binding of antiplatelet 
antibodies detected in patients with septicemia and normal platelets is 
completely or partially EDTA-dependent. They suggested, the damaged 
platelets in patients with septicemia could expose cryptic antigens and 
induce the synthesis of antiplatelet antibodies. 
         The antibodies are autoantibodies of all the major classes. But, 
IgG antibodies are much more frequently involved than IgM antibodies, 
and IgA antibodies are rarely involved [14, 27]. These autoantibodies are 
naturally occurring antibodies with antiplatelet activity, devoid of 
pathologic significance and are capable of recognizing cryptic antigens 
expressed by aged or damaged platelets to remove these from 
circulation[25]. 
        Role of EDTA: The chelating effect of EDTA is in some way 
responsible for agglutination of platelets. The GP IIb/IIIa glycoprotein 
complex in platelet membrane requires the presence of calcium ions to 
maintain its heterodimeric structure. EDTA because of its chelating effect 
can dissociate GP II b/IIIa complex, resulting in exposure of the target 
epitopes on GP IIb [15, 28].This alteration in confirmation of GP IIb/IIIa 
is also associated with temperature[28]. 
          However, EDTA is the most commonly used anticoagulant 
which prevents aggregation of cells and therefore used for blood cell 
counts. It does not cause platelet clumping in all the cases, but only in 
cases of EDTA-PTCP. This is probably related to the concentration of 
EDTA and represents the characteristic inhibitory effect of EDTA on 
platelet stickiness at higher concentrations of EDTA [1]. 
          The pseudothrombocytopenia can also be because of 
technique related variables. Platelet clumping may be the result of poor 
mixing – too little and/or too late mixing, and/or a small, whole blood 
clot or small fibrin clots in an EDTA anticoagulated specimen. The 
improper collection of blood sample may cause thrombin release and a 
falsely low platelet count due to aggregation [29].  
        In the present study, the mean automated platelet counts in 
CPT anticoagulated blood at 0-30 minutes and at 3-4 hours as well as at 
24 hours after blood collection were found to be comparable with the 
mean manual platelet counts (Table: 1, 2). Thus, the CPT anticoagulant 
was found to be a better anticoagulant for getting correct platelet counts 
in cases of EDTA- dependent pseudothrombocytopenia. These findings 
are consistent with that reported by Lippi et al [17]. 
       Tri-sodium citrate do not alter cell counting and sizing after 
sampling in CPT mixture. Pyridoxal 5’- phosphate prevents platelet 
aggregation as it exhibits remarkable anti-aggregant and dis-aggregant effect 
in vitro. The pH is brought to neutrality by adding Tris to the CPT mixture.        
Thus, inhibition of both platelet reaction and aggregation is 
prevented in CPT anticoagulant [17, 20]. Therefore, in routine hematological 
practice, CPT can be an alternative anticoagulant to K3.EDTA, most suitable 
for automated complete blood count and useful in avoiding EDTA-induced 
platelet clumping. 
PTCP is time – dependent phenomenon, gradually developing 
in 0-2 hours of venepuncture [30-31]. Platelet agglutination is detectable 
within minutes and maximum after 60-90 min. The magnitude of 
agglutination and the rate at which the clumping proceeded were 
strongly affected by the platelet concentration in the mixture. In most, 
the agglutination persisted without disaggregation for more than 24 
hours [30]. The size of the aggregates approximates to that of the 
lymphocytes; often giving rise to suspect flag “platelet clumping” and /or 
flagging of the platelet parameters [31].                             
In the present study, comparison of platelet count in EDTA 
anticoagulated blood at different time intervals showed significant 
difference between initial platelet count and that at 0-30 minutes and 
between initial platelet count and that at 3-4 hours. But, no statistical 
change was found in platelet count from 0-30 minutes to 3-4 hours in 
EDTA anticoagulated blood (Table 3). 
Similarly, the comparison of initial platelet count in EDTA with 
platelet counts in CPT anticoagulated blood at different time intervals 
showed significant difference between initial platelet count in EDTA 
anticoagulated blood with platelet count in CPT anticoagulated blood at 
0-30 minutes and that at 3-4 hours. But no statistical change was found in 
platelet count from 0-30 minutes to 3-4 hours in CPT anticoagulated 
blood (Table 4). 
The lower mean platelet count in initial EDTA blood sample on 
which EDTA-PTCP was suspected is probably because these samples 
were different and collected by the clinical residents and at different 
time. The samples which we personally collected and used for cell counts 
at 0-30 minutes and 3-4 hours, did not show significant difference of cell 
counts with lapse of time over upto 24 hours. However, the counts in 
EDTA anticoagulated blood were still significantly lower than that in 
manual counts and with CPT anticoagulated blood. 
Most of the studies have tried different other anticoagulants to 
get correct platelet count in cases of EDTA-PTCP and have found CPT 
anticoagulant as a better alternative for EDTA in cases of EDTA-PTCP [15, 
17,20]  similar to the present findings. 
Pseudothrombocytopenia can complicate an accurate 
determination of platelet count even with an underlying 
thrombocytopenic disorder. Therefore, the presence of apparently 
obvious cause of thrombocytopenia should not be considered to rule out 
the diagnosis of EDTA-PTCP, which is confirmed by identifying the 
platelet clumping in EDTA anti-coagulated blood[6]. It is thus important 
to be able to distinguish between reduced platelet counts due to 




         Examination of well drawned peripheral blood smear for every case 
of thrombocytopenia is mandatory to rule out platelet clumping (PTCP). 
The new CPT mixture is an effective anticoagulant suitable for routine 
haematology and can be used as better alternative to EDTA in EDTA-
PTCP cases. To get correct platelet count in these cases, the manual 
platelet count is the ‘gold standard’. Unrecognized PTCP may result in 
unnecessary laboratory testing, bone marrow aspirations and 
unwarranted transfusions and will prevent needless evaluations of 
thrombocytopenia and related therapeutic decisions. 
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